At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either the autologous sources of the patient’s own body or allogeneic with the matched donor to treat patients with Scleroderma. We isolate and enrich the viable stem cells which will be infused into the patient.
These cells are administered through one of several methods after a considerable analysis of the patient’s unique history and medical professional’s advice.
In this mode, cells are infused directly at the targeted site of injury through catheter-based delivery.
In this mode, cells are administered in the fat layer of the skin and help regenerate skin cells, promoting restructuring of skin tissue layers.
In this mode, cells are infused through the veins to expand blood volumes in the system, to ensure that the maximum number of cells reach the targeted area.
Infused into the body, stem cells can repopulate the damaged parts of the organ. Through paracrine effects, they differentiate into the damaged cells to restore function and continue to regulate the immune system and promote hormonal balance.
These cells can regulate the immune system and reduce the impact of autoimmune disorders. One of the important properties of mesenchymal stem cells is to promote proper function which can improve the strength of blood vessels and promote synthesis of new vessels. When infused in the deep layer of the skin, these stem cells are known to promote synthesis of lost fibroblasts, keratinocytes, and skin epithelial cells to promote faster restructuring of cells. Thus, with our highly specialized approach, it is now possible to obtain noticeable improvements in patients with Scleroderma as well as improving functional abilities.